Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis C

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 20 articles:
HTML format
Text format



Single Articles


    January 2017
  1. VAN DER REE MH, de Vree JM, Stelma F, Willemse S, et al
    Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.
    Lancet. 2017 Jan 10. pii: S0140-6736(16)31715.
    PubMed     Text format     Abstract available


  2. ZEISEL MB, Baumert TF
    Clinical development of hepatitis C virus host-targeting agents.
    Lancet. 2017 Jan 10. pii: S0140-6736(17)30043.
    PubMed     Text format    


    November 2016
  3. GHINEA N, Lipworth W, Day R, Hill A, et al
    Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries.
    Lancet. 2016 Nov 3. pii: S0140-6736(16)32051.
    PubMed     Text format    


    September 2016
  4. MOHAMMADI D
    Lasker Foundation announces award winners for 2016.
    Lancet. 2016;388:1144-5.
    PubMed     Text format    


  5. PIROTH L, Rabaud C, Rey D, Schmit JL, et al
    Hepatitis C: the path towards effective universal therapy.
    Lancet. 2016;388:1051-2.
    PubMed     Text format    


    July 2016
  6. KAMARULZAMAN A, Reid SE, Schwitters A, Wiessing L, et al
    Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30769.
    PubMed     Text format     Abstract available


  7. ALTICE FL, Azbel L, Stone J, Brooks-Pollock E, et al
    The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30856.
    PubMed     Text format     Abstract available


  8. RICH JD, Beckwith CG, Macmadu A, Marshall BD, et al
    Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30379.
    PubMed     Text format     Abstract available


  9. DOLAN K, Wirtz AL, Moazen B, Ndeffo-Mbah M, et al
    Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30466.
    PubMed     Text format     Abstract available


    May 2016
  10. 'T HOEN EF
    Indian hepatitis C drug patent decision shakes public health community.
    Lancet. 2016 May 26. pii: S0140-6736(16)30656.
    PubMed     Text format    



  11. Hepatitis C: global ambition, national realities.
    Lancet. 2016;387:1970.
    PubMed     Text format    


  12. KELLY D
    Hepatitis C viraemia after apparent spontaneous clearance.
    Lancet. 2016;387:1968.
    PubMed     Text format    


  13. INDOLFI G, Mangone G, Bartolini E, Moriondo M, et al
    Hepatitis C viraemia after apparent spontaneous clearance in a vertically infected child.
    Lancet. 2016;387:1967-8.
    PubMed     Text format    


    March 2016
  14. CORRIGAN M, Alrubaiy L, China L
    Hepatology training in the UK.
    Lancet. 2016;387:1055.
    PubMed     Text format    


    January 2016
  15. MCCALL C
    Australia commits funds to curb hepatitis C epidemic.
    Lancet. 2016;387:419.
    PubMed     Text format    


    November 2015
  16. WILLIAMS R, Ashton K, Aspinall R, Bellis MA, et al
    Implementation of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2015;386:2098-111.
    PubMed     Text format    



  17. Hepatitis C: cost of lost opportunities.
    Lancet. 2015;386:1917.
    PubMed     Text format    


    October 2015
  18. JADOUL M, Horsmans Y
    Towards eradication of hepatitis C virus from dialysis units.
    Lancet. 2015 Oct 5. pii: S0140-6736(15)00381.
    PubMed     Text format    


  19. ROTH D, Nelson DR, Bruchfeld A, Liapakis A, et al
    Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.
    Lancet. 2015 Oct 5. pii: S0140-6736(15)00349.
    PubMed     Text format     Abstract available


    August 2015
  20. BRAILLON A
    Interferon-free treatments against HCV are far from free.
    Lancet. 2015;386:856.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: